CHA AI Healthkare Finalizes 5 Billion Won Convertible Bond Issuance, Long-Term Dilution Burden and Financial Uncertainty Persist
CHA AI Healthkare has finalized the issuance of 5 billion won in 32nd series convertible bonds to Cha Care, the largest investor of its largest shareholder, with payment date on June 19, 2026.
The conversion price of 12,463 won is 90.9% higher than the current stock price of 6,320 won, so no immediate dilution occurs, but the conversion price can be adjusted down to 8,725 won if the stock price falls, creating potential dilution risk.
Combined with the existing 36th series CB of 40 billion won, total convertible shares amount to 4.9 million shares, equivalent to 26.97% of outstanding shares, posing a significant long-term dilution burden on shareholder value.
Frequent amendments and issuance delays reflect difficulties in fundraising and indicate financial uncertainty.
[AI Summary]CHA AI Healthkare successfully raised 5 billion won through a private placement of convertible bonds to a related party of its largest shareholder, with no immediate dilution due to the high conversion price. However, if the stock price does not recover, downward adjustment of the conversion price could expand dilution risk, and the combined 27% potential dilution from the existing 40 billion won CBs may negatively impact shareholder value.
KOSPI Filing Information
Result of Issuance of Rights Offering or Equity-Related Bonds (Voluntary Disclosure)